Advances in Gene Expression Profiling (Technical Insights)

February 14, 2014

DUBLIN, February 14, 2014 /PRNewswire/ –

Research and Markets (
http://www.researchandmarkets.com/research/ttlq24/advances_in_gene) has announced the
addition of the “Advances in Gene Expression Profiling (Technical Insights)”
[http://www.researchandmarkets.com/research/ttlq24/advances_in_gene ] report to their

http://photos.prnewswire.com/prnh/20130307/600769 )

The industry dynamics of gene expression profiling are constantly changing. There are
novel technologies emerging with high throughput and more sensitivity. Currently gene
expression profiling techniques are being utilized in drug discovery, clinical diagnostics
and basic research. The applications areas of gene expression spans across communicable
and non-communicable disease and goes far enough to cover lifestyle disorders such as
obesity. Novel data management techniques are needed, due to frustrating challenges of
lack of data storage options and uninterpretable raw genomic data which has led software
companies to look at it as an investment hotspot.


Gene expression profiling encompasses a wide range of technologies, techniques and
data informatics operations. The scientific understanding of gene expression profiling is
to quantify the amount of mRNA and protein that is being expression in a sample or across
multiple samples at any given time for populations. Methods such as microarray techniques,
reverse transcription polymerase chain reaction (PCR) and RNA sequencing are constantly
evolving and being adopted in healthcare and biotechnology towards the development of
diagnostic and therapeutics assays, biomarkers, drug discovery and development, discovery
of novel pathways in disease and understanding gene function and pathogenesis of diseases.
These application areas are highly relevant especially in this era of personalized
medicine.” The relevance of gene expression profiling being used as a science for the
development of therapeutic and diagnostic tools spans across several disease types such as
cancer, cardiovascular disease, neurodegenerative disease in addition to a whole host of
infectious diseases. It also plays a crucial role in prenatal screening and genetic
testing space.

Managing the large amount of genomic data produced through expression profiling
technologies such as microarrays and RNAsequencing is another area which is facing rapid
growth. There are a plethora of opportunities emerging making genomic data management a
hotbed for investors. Majority of the funds that seem to be coming into this sector have
been going towards the development of data storage, analysis and visualization tools that
can potentially eliminate the pertinent challenges present in the industry.

Key Topics Covered:

        Executive Summary
        Research Scope
        Research Process
        Research Methodology
        Key Findings

        Technology Snapshot and Trends
        Technology Overview
        Technology Snapshot
        Technology Capability
        Key Innovations, 2010 to 2013
        Technology Value Chain
        Industry Value Chain

        Impact Assessment and Analysis
        Market Impact of Business Challenges
        Market Impact of Technology Challenges
        Market Impact of Technology/Business Accelerators

        Diffusion of Innovations and Need Assessment
        Technology Adoption Scenario
        Demand Side Needs

        Opportunity Evaluation and Road mapping
        Emerging Opportunities-For Stakeholders
        Emerging Opportunities-For Investors
        Road Mapping

        Gene Expression Profiling-Technology Trends Data Management
        Technology Overview
        Technology Snapshot
        Technology Capability
        Technology Value Chain
        Emerging Opportunities

        Strategic Recommendations for Technology Investors
        Investment Opportunities
        Key Patents and Contacts
        The Frost & Sullivan Story

For more information visit


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net



SOURCE Research and Markets

Source: PR Newswire

comments powered by Disqus